QGEN vs ICLR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 08, 2026

QGEN

42.8
AI Score
VS
QGEN Wins

ICLR

32.9
AI Score

Investment Advisor Scores

QGEN

43score
Recommendation
HOLD

ICLR

33score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric QGEN ICLR Winner
Forward P/E 15.748 17.8253 QGEN
PEG Ratio 1.3566 0.5589 ICLR
Revenue Growth 0.3% -2.9% QGEN
Earnings Growth 7.9% -63.3% QGEN
Tradestie Score 42.8/100 32.9/100 QGEN
Profit Margin 19.5% 5.3% QGEN
Beta 1.00 1.00 Tie
AI Recommendation HOLD EXTENDED Tie

Relative Price Performance (Last 90 Days)

QGEN 1M: +10.7% · 3M: +16.4% ICLR 1M: +22.0% · 3M: +19.7%

Current Technical Phase

QGEN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.0% over 20 days), RSI 66

RSI (14): 66.1 · Price: $50.31

ICLR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.4% over 20 days), RSI 59

RSI (14): 59.1 · Price: $200.46

Fundamentals Snapshot

Metric QGEN ICLR
Market Cap — —
Forward P/E 19.0 17.6
Trailing P/E 27.3 82.1
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.7% 0.2%
Operating Margin 0.3% 0.1%
EPS 1.85 2.53
Dividend Yield 0.01% —

Frequently Asked Questions

Based on our detailed analysis, QGEN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.